Mabpro, a.s.赞助的临床试验
总计1732个结果
-
Koç UniversityVifor Pharma; Abdi Ibrahim Ilac San. ve Tic A.S.招聘中
-
Pharmaceutical Research Unit, JordanAbdi Ibrahim Ilac San. ve Tic A.S.完全的
-
Institute for Clinical and Experimental MedicinePoliklinika Agel, Dopravni zdravotnictvi a.s.招聘中
-
Brno University HospitalKrajská zdravotní a.s. University Hospital Ústí nad Labem未知
-
Pharmaceutical Research Unit, JordanAbdi Ibrahim Ilac San. ve Tic A.S.完全的
-
Federal University of São PauloSoraia Tahan; Mauro Batista de Morais; Mauro Sérgio Toporovski; Clarice Blaj Neufeld; Thabata Koester...完全的
-
SOTIO a.s.European Network of Gynaecological Oncological Trial Groups (ENGOT)撤销卵巢癌 | 输卵管癌 | 腹膜癌
-
Merck KGaA, Darmstadt, GermanyMerck B.V., Netherlands; Merck A.E., Greece; Merck OY, Finland; Merck A.B., Sweden; Merck, S.A., Portugal完全的
-
A.O. Ospedale Papa Giovanni XXIII招聘中
-
University of FloridaALS Association主动,不招人
-
AHS Cancer Control AlbertaCelgene主动,不招人
-
Massachusetts General HospitalALS Association完全的
-
A.O. Ospedale Papa Giovanni XXIII完全的继发于 SARS-COV-2 感染的严重急性呼吸系统综合症 (ARDS)意大利
-
AHS Cancer Control AlbertaPfizer完全的
-
Bukwang PharmaceuticalContera Pharma ApS完全的
-
Clover Biopharmaceuticals AUS Pty Ltd终止
-
A.O. Ospedale Papa Giovanni XXIII主动,不招人
-
Massachusetts General HospitalALS Association完全的
-
A.O. Ospedale Papa Giovanni XXIII完全的